News

Harbor BioSciences retains the rights to these products in US and rest of the world, and CIPI will provide the company all the pre-clinical and clinical data it

Microbix Biosystems is a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products. Earlier, Baron

CureFAKtor Pharma is intending to conduct a Phase I clinical study of CFAK-C4 in combination with gemcitabine chemotherapy in 2012. CureFAKtor Pharma president and CEO Shep Wild said

Mylan Pharmaceuticals, a subsidiary of Mylan Inc, has claimed that its Acarbose tablets is the generic version of Bayer’s Precose tablets, a treatment to be used with diet

Under the plan, R5 Pharma, a subsidiary of Aesica Pharmaceuticals, plans to build a new analytical chemistry laboratory this spring with the second stage of construction completing in

The EverFlex+ Self-Expanding Peripheral Stent System is the advanced version of EverFlex stent technology for the treatment of peripheral arterial disease. The new EverFlex+ system is designed to

The joint venture is expected to be renamed as Vertellus Specialty Materials (India) for the marketing and distribution of specialty chemicals globally Vertellus Specialties is the majority partner

The new system, which will help in the production of self-adhesive labels, consists of machine mounted cameras that compare every label produced to the customer’s approved artwork. The

TransPharma’s ViaDor drug delivery system incorporates a handheld electronic device, which creates microscopic passageways through the outer layer of the skin allowing for transdermal delivery of a wide